FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71 | -39.3% | 24,951 | +55.6% | 0.00% | 0.0% |
| Q4 2022 | $117 | -99.9% | 16,033 | +35.5% | 0.00% | 0.0% |
| Q3 2022 | $96,000 | +47.7% | 11,835 | -10.2% | 0.00% | 0.0% |
| Q2 2022 | $65,000 | -35.6% | 13,173 | +207.1% | 0.00% | 0.0% |
| Q1 2022 | $101,000 | -51.9% | 4,289 | -63.8% | 0.00% | 0.0% |
| Q4 2021 | $210,000 | -61.3% | 11,852 | -38.4% | 0.00% | -66.7% |
| Q3 2021 | $542,000 | +330.2% | 19,228 | +180.2% | 0.00% | +200.0% |
| Q2 2020 | $126,000 | – | 6,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |